Financials

News Ideas Discussions Technicals Forecast Seasonals

IPHA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Innate Pharma S.A. operating, investing, and financing activities

IPHA free cash flow for H1 24 is 2.98 M USD. For 2023, IPHA free cash flow was -35.58 M USD and operating cash flow was -35.2 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—